{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:21:49Z","timestamp":1783034509310,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["22K09824"],"award-info":[{"award-number":["22K09824"]}]},{"name":"JSPS KAKENHI","award":["24K12754"],"award-info":[{"award-number":["24K12754"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51576-x","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T16:56:05Z","timestamp":1777740965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structure-based virtual screening identifies VX-809 as a candidate dual-pathway modulator in fuchs endothelial corneal dystrophy"],"prefix":"10.1038","volume":"16","author":[{"given":"Shunsuke","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisei","family":"Okino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Numao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theofilos","family":"Tourtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Schl\u00f6tzer-Schrehardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"51576_CR1","doi-asserted-by":"publisher","unstructured":"Engler, C. et al. Unfolded protein response in fuchs endothelial corneal dystrophy: a unifying pathogenic pathway? Am J Ophthalmol 149, 194\u2013202 e192, (2010). https:\/\/doi.org\/10.1016\/j.ajo.2009.09.009","DOI":"10.1016\/j.ajo.2009.09.009"},{"key":"51576_CR2","doi-asserted-by":"publisher","unstructured":"Jurkunas, U. V., Bitar, M. S., Funaki, T. & Azizi, B. Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy. The Am. J. pathology 177, 2278\u20132289, https:\/\/doi.org\/10.2353\/ajpath.2010.100279 S0002-9440(10)60281-7 [pii] (2010).","DOI":"10.2353\/ajpath.2010.100279"},{"key":"51576_CR3","doi-asserted-by":"publisher","first-page":"100863","DOI":"10.1016\/j.preteyeres.2020.100863","volume":"80","author":"S Ong Tone","year":"2021","unstructured":"Ong Tone, S. et al. Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis. Prog Retin Eye Res. 80, 100863. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100863 (2021).","journal-title":"Prog Retin Eye Res."},{"key":"51576_CR4","doi-asserted-by":"publisher","first-page":"100883","DOI":"10.1016\/j.preteyeres.2020.100883","volume":"81","author":"MP Fautsch","year":"2021","unstructured":"Fautsch, M. P. et al. TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat-associated disease. Prog Retin Eye Res. 81, 100883. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100883 (2021).","journal-title":"Prog Retin Eye Res."},{"key":"51576_CR5","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1089\/ars.2015.6532","volume":"24","author":"A Halilovic","year":"2016","unstructured":"Halilovic, A. et al. Menadione-Induced DNA Damage Leads to Mitochondrial Dysfunction and Fragmentation During Rosette Formation in Fuchs Endothelial Corneal Dystrophy. Antioxid. Redox Signal. 24, 1072\u20131083. https:\/\/doi.org\/10.1089\/ars.2015.6532 (2016).","journal-title":"Antioxid. Redox Signal."},{"key":"51576_CR6","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.1038\/s41598-017-06924-3","volume":"7","author":"N Okumura","year":"2017","unstructured":"Okumura, N. et al. Activation of TGF-\u03b2 signaling induces cell death via the unfolded protein response in Fuchs endothelial corneal dystrophy. Sci. Rep. 7, 6801. https:\/\/doi.org\/10.1038\/s41598-017-06924-3 (2017).","journal-title":"Sci. Rep."},{"key":"51576_CR7","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1167\/iovs.16-21023","volume":"58","author":"N Okumura","year":"2017","unstructured":"Okumura, N. et al. Sustained Activation of the Unfolded Protein Response Induces Cell Death in Fuchs\u2019 Endothelial Corneal Dystrophy. Invest. Ophthalmol. Vis. Sci. 58, 3697\u20133707. https:\/\/doi.org\/10.1167\/iovs.16-21023 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"51576_CR8","doi-asserted-by":"publisher","first-page":"110334","DOI":"10.1016\/j.exer.2025.110334","volume":"255","author":"T Nakagawa","year":"2025","unstructured":"Nakagawa, T. et al. Involvement of TGF-\u03b2 signaling pathway-associated genes in the corneal endothelium of patients with Fuchs endothelial corneal dystrophy. Exp. Eye Res. 255, 110334. https:\/\/doi.org\/10.1016\/j.exer.2025.110334 (2025).","journal-title":"Exp. Eye Res."},{"key":"51576_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1167\/iovs.66.11.63","volume":"66","author":"T Onishi","year":"2025","unstructured":"Onishi, T. et al. The PERK-p38 MAPK Axis Drives Endoplasmic Reticulum Stress-Induced Apoptosis in Fuchs Endothelial Corneal Dystrophy. Invest. Ophthalmol. Vis. Sci. 66, 63. https:\/\/doi.org\/10.1167\/iovs.66.11.63 (2025).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"51576_CR10","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1021\/jm5006463","volume":"57","author":"A Anighoro","year":"2014","unstructured":"Anighoro, A., Bajorath, J. & Rastelli, G. Polypharmacology: challenges and opportunities in drug discovery: miniperspective. J. Med. Chem. 57, 7874\u20137887 (2014).","journal-title":"J. Med. Chem."},{"key":"51576_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.drudis.2015.12.007","volume":"21","author":"A Lavecchia","year":"2016","unstructured":"Lavecchia, A. & Cerchia, C. In silico methods to address polypharmacology: current status, applications and future perspectives. Drug Discovery Today. 21, 288\u2013298 (2016).","journal-title":"Drug Discovery Today"},{"key":"51576_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/17460441.2018.1413089","volume":"13","author":"B Ravikumar","year":"2018","unstructured":"Ravikumar, B. & Aittokallio, T. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery. Expert Opin. Drug Discov. 13, 179\u2013192 (2018).","journal-title":"Expert Opin. Drug Discov."},{"key":"51576_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/acs.jmedchem.8b00760","volume":"62","author":"E Proschak","year":"2018","unstructured":"Proschak, E., Stark, H. & Merk, D. Polypharmacology by design: a medicinal chemist\u2019s perspective on multitargeting compounds. J. Med. Chem. 62, 420\u2013444 (2018).","journal-title":"J. Med. Chem."},{"key":"51576_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s43440-023-00501-4","volume":"75","author":"P Ryszkiewicz","year":"2023","unstructured":"Ryszkiewicz, P., Malinowska, B. & Schlicker, E. Polypharmacology: promises and new drugs in 2022. Pharmacol. Rep. 75, 755\u2013770 (2023).","journal-title":"Pharmacol. Rep."},{"key":"51576_CR15","doi-asserted-by":"publisher","first-page":"10150","DOI":"10.3390\/molecules190710150","volume":"19","author":"SZ Grinter","year":"2014","unstructured":"Grinter, S. Z. & Zou, X. Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design. Molecules 19, 10150\u201310176 (2014).","journal-title":"Molecules"},{"key":"51576_CR16","first-page":"1029","volume":"3","author":"KK Chaudhary","year":"2016","unstructured":"Chaudhary, K. K. & Mishra, N. A review on molecular docking: novel tool for drug discovery. Databases 3, 1029 (2016).","journal-title":"Databases"},{"key":"51576_CR17","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2019","unstructured":"Pinzi, L. & Rastelli, G. Molecular docking: shifting paradigms in drug discovery. Int. J. Mol. Sci. 20, 4331 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"51576_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-biochem-030222-120000","volume":"93","author":"JM Paggi","year":"2024","unstructured":"Paggi, J. M., Pandit, A. & Dror, R. O. The art and science of molecular docking. Annu. Rev. Biochem. 93, 389\u2013410 (2024).","journal-title":"Annu. Rev. Biochem."},{"key":"51576_CR19","doi-asserted-by":"publisher","first-page":"228831","DOI":"10.1109\/ACCESS.2020.3046190","volume":"8","author":"M Kokabi","year":"2020","unstructured":"Kokabi, M., Donnelly, M. & Xu, G. Benchmarking small-dataset structure-activity-relationship models for prediction of Wnt signaling inhibition. IEEE Access. 8, 228831\u2013228840 (2020).","journal-title":"IEEE Access."},{"key":"51576_CR20","doi-asserted-by":"crossref","unstructured":"Mao, J. et al. Comprehensive strategies of machine-learning-based quantitative structure-activity relationship models. Iscience 24,  103052 (2021).","DOI":"10.1016\/j.isci.2021.103052"},{"key":"51576_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.drudis.2012.03.017","volume":"17","author":"MJ Harvey","year":"2012","unstructured":"Harvey, M. J. & De Fabritiis, G. High-throughput molecular dynamics: the powerful new tool for drug discovery. Drug discovery today. 17, 1059\u20131062 (2012).","journal-title":"Drug discovery today"},{"key":"51576_CR22","doi-asserted-by":"crossref","unstructured":"Chitara, D. & Sanjeev, B. Big Data Approach to Large Scale Molecular Dynamics Simulations: Necessity and Inevitability for Drug Design. (2021).","DOI":"10.20944\/preprints202109.0275.v1"},{"key":"51576_CR23","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2174\/0929867311320130005","volume":"20","author":"X Liu","year":"2013","unstructured":"Liu, X. et al. Predicting targeted polypharmacology for drug repositioning and multi-target drug discovery. Curr. Med. Chem. 20, 1646\u20131661 (2013).","journal-title":"Curr. Med. Chem."},{"key":"51576_CR24","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1080\/08927022.2014.899699","volume":"40","author":"SR Ellingson","year":"2014","unstructured":"Ellingson, S. R., Smith, J. C. & Baudry, J. Polypharmacology and supercomputer-based docking: opportunities and challenges. Mol. Simul. 40, 848\u2013854 (2014).","journal-title":"Mol. Simul."},{"key":"51576_CR25","doi-asserted-by":"crossref","unstructured":"Panos, G. D., Dutton, G. N., Empeslidis, T. & Konstas, A. G. In silico trials in ocular drug development: a new frontier in ophthalmology. Expert Opin. Drug Discov. 20, 1369\u20131376 (2025).","DOI":"10.1080\/17460441.2025.2556863"},{"key":"51576_CR26","doi-asserted-by":"publisher","first-page":"14665","DOI":"10.1038\/s41598-025-95003-z","volume":"15","author":"I Oka","year":"2025","unstructured":"Oka, I. et al. A feasibility of computational drug screening for Fuchs endothelial corneal dystrophy. Sci. Rep. 15, 14665. https:\/\/doi.org\/10.1038\/s41598-025-95003-z (2025).","journal-title":"Sci. Rep."},{"key":"51576_CR27","doi-asserted-by":"publisher","first-page":"103348","DOI":"10.1016\/j.redox.2024.103348","volume":"77","author":"S Saha","year":"2024","unstructured":"Saha, S. et al. TCF4 trinucleotide repeat expansions and UV irradiation increase susceptibility to ferroptosis in Fuchs endothelial corneal dystrophy. Redox Biol. 77, 103348 (2024).","journal-title":"Redox Biol."},{"key":"51576_CR28","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1089\/ars.2007.1782","volume":"9","author":"JD Malhotra","year":"2007","unstructured":"Malhotra, J. D. & Kaufman, R. J. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid. Redox. Signal. 9, 2277\u20132294 (2007).","journal-title":"Antioxid. Redox. Signal."},{"key":"51576_CR29","first-page":"3649","volume":"127","author":"D Eletto","year":"2014","unstructured":"Eletto, D., Chevet, E., Argon, Y. & Appenzeller-Herzog, C. Redox controls UPR to control redox. J. Cell Sci. 127, 3649\u20133658 (2014).","journal-title":"J. Cell Sci."},{"key":"51576_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/antiox12050981","volume":"12","author":"G Ong","year":"2023","unstructured":"Ong, G. & Logue, S. E. Unfolding the interactions between endoplasmic reticulum stress and oxidative stress. Antioxidants 12, 981 (2023).","journal-title":"Antioxidants"},{"key":"51576_CR31","doi-asserted-by":"publisher","first-page":"18843","DOI":"10.1073\/pnas.1105787108","volume":"108","author":"F Van Goor","year":"2011","unstructured":"Van Goor, F. et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc. Natl. Acad. Sci. 108, 18843\u201318848 (2011).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"51576_CR32","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.chembiol.2013.06.004","volume":"20","author":"CM Farinha","year":"2013","unstructured":"Farinha, C. M. et al. Revertants, low temperature, and correctors reveal the mechanism of F508del-CFTR rescue by VX-809 and suggest multiple agents for full correction. Chem. Biol. 20, 943\u2013955 (2013).","journal-title":"Chem. Biol."},{"key":"51576_CR33","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1091\/mbc.e13-05-0240","volume":"24","author":"HY Ren","year":"2013","unstructured":"Ren, H. Y. et al. VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1. Mol. Biol. Cell. 24, 3016\u20133024 (2013).","journal-title":"Mol. Biol. Cell"},{"key":"51576_CR34","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.chembiol.2014.02.021","volume":"21","author":"PD Eckford","year":"2014","unstructured":"Eckford, P. D. et al. VX-809 and related corrector compounds exhibit secondary activity stabilizing active F508del-CFTR after its partial rescue to the cell surface. Chem. Biol. 21, 666\u2013678 (2014).","journal-title":"Chem. Biol."},{"key":"51576_CR35","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1124\/mol.119.117143","volume":"96","author":"YS Wu","year":"2019","unstructured":"Wu, Y. S. et al. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel. Mol. Pharmacol. 96, 515\u2013525. https:\/\/doi.org\/10.1124\/mol.119.117143 (2019).","journal-title":"Mol. Pharmacol."},{"key":"51576_CR36","doi-asserted-by":"publisher","unstructured":"Favia, M. et al. Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi(\u00ae)) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21072398 (2020).","DOI":"10.3390\/ijms21072398"},{"key":"51576_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12931-020-01406-z","volume":"21","author":"BS Quon","year":"2020","unstructured":"Quon, B. S. et al. Short-term effects of Lumacaftor\/Ivacaftor (Orkambi\u2122) on exertional symptoms, exercise performance, and ventilatory responses in adults with cystic fibrosis. Respir Res. 21, 135. https:\/\/doi.org\/10.1186\/s12931-020-01406-z (2020).","journal-title":"Respir Res."},{"key":"51576_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/hmg\/ddr473","volume":"21","author":"AS Jun","year":"2012","unstructured":"Jun, A. S. et al. An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. Hum. Mol. Genet. 21, 384\u2013393. https:\/\/doi.org\/10.1093\/hmg\/ddr473 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"51576_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.66.6.18","volume":"66","author":"Y Oyama","year":"2025","unstructured":"Oyama, Y. et al. Generation of a Mouse Model of Fuchs Endothelial Corneal Dystrophy by Knock-in of CTG Trinucleotide Repeat Expansion in the TCF4 Gene. Invest. Ophthalmol. Vis. Sci. 66, 18. https:\/\/doi.org\/10.1167\/iovs.66.6.18 (2025).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"51576_CR40","doi-asserted-by":"crossref","unstructured":"Sharma, S., Sahoo, R., Chawla, S., Das, S. & Alone, D. P. Generation of FECD Phenotypes in the Mouse Cornea by UVA Exposure and Surgical Removal of its Corneal Endothelial Layer. Bio-protocol 15, e5249 (2025).","DOI":"10.21769\/BioProtoc.5249"},{"key":"51576_CR41","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1016\/s0969-2126(99)80033-1","volume":"7","author":"T Darden","year":"1999","unstructured":"Darden, T., Perera, L., Li, L. & Pedersen, L. New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure 7, R55\u201360. https:\/\/doi.org\/10.1016\/s0969-2126(99)80033-1 (1999).","journal-title":"Structure"},{"key":"51576_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1021\/ct700200b","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess, B. & P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation. J. Chem. Theory Comput. 4, 116\u2013122. https:\/\/doi.org\/10.1021\/ct700200b (2008).","journal-title":"J. Chem. Theory Comput."},{"key":"51576_CR43","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/labinvest.2015.111","volume":"95","author":"N Okumura","year":"2015","unstructured":"Okumura, N. et al. Involvement of ZEB1 and Snail1 in excessive production of extracellular matrix in Fuchs endothelial corneal dystrophy. Lab. Invest. 95, 1291\u20131304. https:\/\/doi.org\/10.1038\/labinvest.2015.111 (2015).","journal-title":"Lab. Invest."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51576-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51576-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51576-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:13:02Z","timestamp":1783033982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51576-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51576"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51576-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Naoki Okumura and Noriko Koizumi are co-founders of ActualEyes Inc., which is currently developing a pharmaceutical therapy for treating Fuchs endothelial corneal dystrophy. Other authors do not have a competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20408"}}